Tamás Garzó
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
- Metabolism and Genetic Disorders
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Biochemistry 16
- Amino Acid Enzymes and Metabolism 6
- Co-authors
- József Mandl (27 shared papers)F. Antoni (23 shared papers)Gábor Bánhegyi (13 shared papers)Miklós Péter Kalapos (14 shared papers)László Braun (5 shared papers)Gábor Bánhegyi (6 shared papers)Emma Hansson (3 shared papers)Miklós Csala (3 shared papers)
In The Last Decade
Tamás Garzó
47 papers receiving 571 citations
Peers
Comparison fields: 5 of 81
- Clinical Biochemistry 143
- Biochemistry 98
- Pharmacology 108
- Nutrition and Dietetics 101
- Physiology 119
Countries citing papers authored by Tamás Garzó
This map shows the geographic impact of Tamás Garzó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamás Garzó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamás Garzó more than expected).
Fields of papers citing papers by Tamás Garzó
This network shows the impact of papers produced by Tamás Garzó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamás Garzó. The network helps show where Tamás Garzó may publish in the future.
Co-authors
The 25 scholars most cited alongside Tamás Garzó, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 51 | |
| 2 | 1988 | 47 | |
| 3 | 1996 | 42 | |
| 4 | 1994 | 33 | |
| 5 | 1996 | 33 | |
| 6 | 1993 | 32 | |
| 7 | 1995 | 27 | |
| 8 | 1991 | 25 | |
| 9 | 1984 | 25 | |
| 10 | 1991 | 24 | |
| 11 | 1982 | 18 | |
| 12 | 1988 | 17 | |
| 13 | 1996 | 16 | |
| 14 | 1962 | 15 | |
| 15 | 1976 | 14 | |
| 16 | 1982 | 14 | |
| 17 | 1962 | 13 | |
| 18 | 1991 | 12 | |
| 19 | 1994 | 12 | |
| 20 | 1995 | 11 |
About Tamás Garzó
Tamás Garzó is a scholar working on Molecular Biology, Biochemistry, Clinical Biochemistry, Physiology and Pharmacology, having authored 47 papers that have together received 618 indexed citations. Recurring topics across this work include Biochemical effects in animals (7 papers), Metabolism and Genetic Disorders (7 papers), Pharmacogenetics and Drug Metabolism (7 papers), Advanced Glycation End Products research (7 papers), Enzyme Production and Characterization (6 papers), Amino Acid Enzymes and Metabolism (6 papers), Vitamin C and Antioxidants Research (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Clinical Biochemistry (143 citations), Biochemistry (98 citations), Pharmacology (108 citations), Nutrition and Dietetics (101 citations) and Physiology (119 citations). Tamás Garzó has collaborated with scholars based in Hungary, Italy and France. Frequent co-authors include József Mandl, F. Antoni, Gábor Bánhegyi, Miklós Péter Kalapos, László Braun, Gábor Bánhegyi, Emma Hansson, Miklós Csala, J. Mandl and Raymund Machovich. Their work appears in journals such as FEBS Letters, Biochemical Pharmacology, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Thrombosis Research and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.